More News

13 Jan 2007 Biocoral, Inc. Announces the Results of the Final Report of its Prospective Randomised Clinical Multi-Centre Trial for Treatment of Hip Fractures Associated With Natural Bone Demineralization/or Low Bone Mass
12 Jan 2007 Bristol-Myers Squibb and AstraZeneca Announce Worldwide Collaboration to Develop and Commercialize Diabetes Compounds
12 Jan 2007 Immuno-Biological Laboratories Co., Ltd. and Intellect Neurosciences, Inc. Enter into Humanized Monoclonal Antibodies Development Agreement for the Treatment of Alzheimer's Disease
12 Jan 2007 KINAXO Announces Agreement with Johnson & Johnson
12 Jan 2007 Wyeth and Solvay Enter Into an Additional Neuroscience Collaboration
11 Jan 2007 Organon and the Academic Medical Center jointly develop novel treatment of rheumatoid arthritis
11 Jan 2007 InteKrin Therapeutics Licenses Diabetes Product
10 Jan 2007 Archemix Announces Collaboration with Pfizer to Discover Aptamer Therapeutics
10 Jan 2007 Organon partners with HUYA to identify and develop Chinese biopharmaceuticals
10 Jan 2007 Alnylam and Inex Form Strategic Technology Alliance to Discover and Develop RNAi Therapeutics with Lipid-Based Delivery Formulations
10 Jan 2007 Alnylam and Inex Form Strategic Technology Alliance to Discover and Develop RNAi Therapeutics with Lipid-Based Delivery Formulations
10 Jan 2007 Mirus Bio Corporation Enters Into Agreement with Pfizer Inc to Evaluate RNAi Delivery Technology
10 Jan 2007 Mirus Bio Corporation Enters Into Agreement with Pfizer Inc to Evaluate RNAi Delivery Technology
09 Jan 2007 Xytis merges and raises $24.5M
09 Jan 2007 Ablynx and Boehringer Ingelheim sign $265 million research and licensing agreement to develop new Alzheimer's treatments
09 Jan 2007 Alkermes and Lilly Expand AIR(R) Inhaled Insulin Collaboration
09 Jan 2007 PTC Therapeutics Announces Strategic Drug Discovery Collaboration With Pfizer Utilizing PTC’S Gems Technology Platform
09 Jan 2007 Seattle Genetics to Present at the JPMorgan Annual Healthcare Conference
09 Jan 2007 Cytochroma Inc. and aOvaTechnologies, Inc., Sign License Agreement.
09 Jan 2007 Cambridge Antibody Technology Licenses Monoclonal Antibody (CAT-213) For Treatment Of Allergy Disorders To iCO Therapeutics
09 Jan 2007 Seattle Genetics and Agensys Announce Collaboration to Co-Develop and Commercialize Antibody-Drug Conjugate Therapies for Cancer
08 Jan 2007 Catalyst Biosciences And Wyeth Pharmaceuticals Sign Two Agreements For Novel Biotherapeutic Platform Of Engineered Proteases
06 Jan 2007 Tengion Launches First Phase II Clinical Trial of Regenerated Human Organ
06 Jan 2007 DSM Biologics and Crucell Announce PER.C6(R) Licensing Agreement with Biotecnol SA for Antibody Production
06 Jan 2007 Provid Pharmaceuticals Inc. To Acquire Tripos Discovery Research

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top